SimCorp to transform private market investing with SimCorp Alternatives
Highlights: SimCorp launches SimCorp Alternatives, a comprehensive offering designed to serve the…
Ipsen – July 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital
Monthly information relative to the total number of voting rights and shares…
Nicox Announces Positive Results from the NCX 470 Phase 3 Denali Trial in Glaucoma Patients
August 21, 2025 01:30 ET Â | Source: NICOX SA Press Release Nicox…
Introducing Miutine, the new irreverent, fragrance by Miu Miu
PARIS, Aug. 19, 2025 /PRNewswire/ -- Miu Miu unveils Miutine, the new…
HR Path Strengthens Global Presence with Strategic Acquisition of RKM Consulting in Australia
PARIS, Aug. 14, 2025 /PRNewswire/ -- HR Path, a global leader in…
HR Path Strengthens Global Presence with Strategic Acquisition of PredictiveHR
PARIS, Aug. 6, 2025 /PRNewswire/ -- HR Path, a global leader in…
Safeguarding the Games: Welfare Officers play vital role at Paris 2024
07 August 2025 - On the occasion of Safe Sport Day, the IOC highlights some…
Artmarket.com: Double-digit growth in Q2 2025, Revolutionary Artprice-Perplexity AI rapprochement: The Mixed Subscription for the Second Half of 2025/2026 Will Redefine the Intelligence of the Art Market
PARIS, Aug. 7, 2025 /PRNewswire/ -- The Board of Directors, its founding…
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ in Elderly and Updates to the Prescribing Information
Saint Herblain (France), August 7, 2025 – Valneva SE (Nasdaq: VALN; Euronext…
Atos – Half-year 2025 results on track. Full Year 2025 targets confirmed
Press Release Half-year 2025 results on track Full Year 2025 targets confirmed…